Examkin

Soru

Zorluk: ZorNeonatal Disorders

A term neonate born to a mother with blood type O, Rh-negative develops visible scleral and cutaneous icterus at 24 hours of life. Assuming the infant has confirmed ABO incompatibility and the clinical condition progressively worsens despite each preceding intervention, arrange the following diagnostic and therapeutic steps in the correct escalating chronological sequence.

  1. 1Perform transcutaneous bilirubinometry (TcB)
  2. 2Measure total serum bilirubin (TSB) and obtain a direct antiglobulin test (DAT)
  3. 3Initiate intensive phototherapy
  4. 4Administer intravenous immunoglobulin (IVIG)
  5. 5Perform double-volume exchange transfusion

Cevap

The correct escalating sequence for managing progressive neonatal isoimmune hyperbilirubinemia is: TcB screening, TSB and DAT confirmation, initiation of intensive phototherapy, administration of IVIG, and finally double-volume exchange transfusion.
The management of neonatal hyperbilirubinemia follows a strict step-wise escalation. Initial non-invasive screening (TcB) dictates the need for confirmatory invasive testing (TSB/DAT). Once pathologic levels are confirmed, non-invasive treatment (phototherapy) is initiated. If immune-mediated hemolysis drives a continued rise in bilirubin despite phototherapy, medical blockade of hemolysis (IVIG) is warranted. Finally, if all medical interventions fail and bilirubin reaches neurotoxic levels, mechanical removal via double-volume exchange transfusion is the definitive life-saving intervention.

Adım Adım Çözüm

1
Identify the initial screening requirement.
Transcutaneous bilirubinometry (TcB) is selected.
TcB provides a rapid, non-invasive estimate of bilirubin levels to determine if invasive blood draws are necessary.
2
Confirm pathologic bilirubin levels and etiology.
Total serum bilirubin (TSB) and direct antiglobulin test (DAT) are ordered.
Visible jaundice at 24 hours is pathologic until proven otherwise; TSB provides exact values for treatment nomograms, and DAT confirms ABO/Rh isoimmunization.
3
Select the first-line therapeutic intervention.
Intensive phototherapy is initiated.
Phototherapy structurally converts unconjugated bilirubin into water-soluble isomers that can be excreted in urine and bile, acting as the standard initial treatment.
4
Determine the next pharmacological step for refractory isoimmune hemolysis.
Intravenous immunoglobulin (IVIG) is administered.
In ABO or Rh incompatibility where bilirubin continues to rise despite phototherapy, IVIG reduces hemolysis by blocking macrophage Fc receptors.
5
Identify the definitive rescue therapy for impending neurotoxicity.
Double-volume exchange transfusion is performed.
When extreme hyperbilirubinemia threatens to cause kernicterus despite all medical interventions, mechanically replacing the infant's blood rapidly removes bilirubin and maternal antibodies.

Anahtar Kavram

Escalating management of isoimmune neonatal hyperbilirubinemia
Bu soruyu puanla

Konular

Neonatal Disorders

Bu konudan daha fazla soru